» Articles » PMID: 2068892

Comparison of Acid Ethanol Extraction and Acid Gel Filtration Prior to IGF-I and IGF-II Radioimmunoassays: Improvement of Determinations in Acid Ethanol Extracts by the Use of Truncated IGF-I As Radioligand

Overview
Specialty Endocrinology
Date 1991 Jun 1
PMID 2068892
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factor binding proteins interfere in the IGF-I and -II radioimmunoassays. In an attempt to overcome this problem, we have compared the use of truncated IGF-I, with reduced IGFBP affinity, and IGF-I as radioligands for IGF-I RIA measurements in serum separated by acid gel filtration or acid ethanol extraction followed by cryo-precipitation. With truncated IGF-I as radioligand the IGF-I measurements in acid gel filtrates and acid ethanol extracts were significantly correlated in healthy subjects (N = 42, r = 0.91, p less than 0.001) and in patients with acromegaly (N = 10, r = 0.85, p less than 0.01), GH deficiency (N = 10, r = 0.88, p less than 0.001) or Type I diabetes mellitus (N = 10, r = 0.90, p less than 0.001). In contrast, the IGF-I concentrations in acid ethanol extracts determined with IGF-I as radioligand did not correlate with those in acid gel filtrates using truncated IGF-I radioligand in patients with acromegaly (r = 0.61, NS) or GH deficiency (r = 0.46, NS). In the latter group the mean IGF-I concentrations measured in acid ethanol extracts were erroneously elevated by 112%. Low-affinity antibodies used for IGF-II RIA determinations failed to give reliable results in acid ethanol extracts from patients with Type I diabetes mellitus or GH deficiency. In conclusion, erroneously high IGF-I concentrations owing to binding of the radioligand to IGFBPs not completely removed by acid ethanol extraction can be avoided by the use of truncated IGF-I as radioligand.

Citing Articles

The 5:2 Diet Affects Markers of Insulin Secretion and Sensitivity in Subjects with and without Type 2 Diabetes-A Non-Randomized Controlled Trial.

Ekberg N, Hellberg A, Sundqvist M, Linden Hirschberg A, Catrina S, Brismar K Int J Mol Sci. 2024; 25(17).

PMID: 39273678 PMC: 11395907. DOI: 10.3390/ijms25179731.


Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes.

Brismar K, Hilding A, Ansurudeen I, Flyvbjerg A, Frystyk J, Ostenson C Front Endocrinol (Lausanne). 2023; 13:1092307.

PMID: 36686443 PMC: 9849561. DOI: 10.3389/fendo.2022.1092307.


IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes.

Eklund E, Hellberg A, Berglund B, Brismar K, Linden Hirschberg A Front Endocrinol (Lausanne). 2021; 12:708421.

PMID: 34484121 PMC: 8415455. DOI: 10.3389/fendo.2021.708421.


Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate.

Botusan I, Zheng X, Narayanan S, Grunler J, Sunkari V, Calissendorff F PLoS One. 2018; 13(3):e0193084.

PMID: 29534073 PMC: 5849293. DOI: 10.1371/journal.pone.0193084.


Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Alehagen U, Johansson P, Aaseth J, Alexander J, Brismar K PLoS One. 2017; 12(6):e0178614.

PMID: 28609475 PMC: 5469470. DOI: 10.1371/journal.pone.0178614.